It is sometimes hard to believe how many Americans continue to smoke despite the overwhelming evidence of harm to health. Cigarette smoking remains the single biggest cause of preventable death in the United States. It leads to a lot of health spending. It tends to afflict persons in lower socioeconomic classes disproportionately. A number of smoking cessation interventions have been developed, with varying degrees of success. Research reported in the Journal of the American Medical Association evaluates an intervention designed to bridge the transition from hospital to home for patients who wish to stop tobacco use. (JAMA Article) The Joint Commission on hospital accreditation has a quality measure requiring hospitals to identify smokers and offer smoking cessation programs to patients. Hospital stays are usually short-term, however, and quitting tobacco use is a lengthy and difficult process. The study tested an intervention designed to create continuity for patients identified as smokers and who wished to enter into a tobacco cessation program while in the hospital. The study was conducted in a single, prominent Boston hospital and randomized patients to the intervention or usual care. The intervention included a free smoking cessation medication, with regular automated telephone calls giving support messages and encouraging patients to call if they had questions or were having difficulty quitting. The return calls were made by a trained counselor. The primary outcome was tobacco cessation after 6 months, as validated by a biochemical test. Patients in the intervention group were more like to use smoking cessation treatment during the first month following discharge from the hospital, by about 83% to 63%. This difference continued throughout the 6 month followup period. 61% of the intervention patients completed 8 or more weeks of the 12 week treatment course compared to only 37% of the usual care patients. At the primary outcome, 26% of intervention patients demonstrated no tobacco use compared to only 15% of usual care patients. The incremental costs per patient for the intervention were $540 in the first year. This particular intervention appears to be effective compared to usual care, but it is discouraging that even with the intervention the quit rate is low. This demonstrates just how hard it is to change tobacco use behavior. Given the health harms, and financial harms to often low-income users, it is worth spending a lot of time on how to get people off tobacco, but even better would be figuring out how to keep them from starting in the first place.
A Successful Smoking Cessation Intervention
By Kevin RocheDecember 4, 2014Commentary
✅ Subscribe via Email
About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at [email protected].
Healthy Skeptic Podcast
This is an outstanding report on total global drug spending and trends, with projections out to 2025. It helps you understand this important area of health care, which does much...
June 1, 2021
MedPAC 2019 Report to Congress
June 18, 2019
Another example of over-priced companies trying to find some way to survive in the post-epidemic financial world. Transcarent, which does something, somehow to “access high quality, affordable care” is buying...
March 6, 2023
In an attempt to swiftly revive two floundering health care companies, a PE firm has announced the merger and recapitalization of Revive Health and SwiftMD. You know they are...
January 30, 2023
Investors have not yet learned their lesson, as Pearl Health gathers a new round of $75 million in capital for its business of supporting physicians who want to participate in...
January 30, 2023
Access ACO Care Management Chronic Disease Comparative Effectiveness Consumer Directed Health Consumers Devices Disease Management Drugs EHRs Elder Care End-of-Life Care FDA Financings Genomics Government Health Care Costs Health Care Quality Health Care Reform Health Insurance Health Insurance Exchange HIT HomeCare Hospital Hospital Readmissions Legislation M&A Malpractice Meaningful Use Medicaid Medical Care Medicare Medicare Advantage Mobile Pay For Performance Pharmaceutical Physicians Providers Regulation Repealing Reform Telehealth Telemedicine Wellness and Prevention Workplace
March 27, 2023
Why You Can’t Trust People Who Make Up Stuff About Vax Safety
A couple of studies offer a far better explanation for heart issues in athletes and…
March 25, 2023
Coronamonomania Lives Forever, Part 201
Tired of March Madness? A boringly refreshing dip into some CV-19 research summaries is recommended.
March 24, 2023
The CDC Is a Font of Methodological and Statistical Error
Several times in the last three years I and others have pointed out serious flaws…